Research ArticleOriginal Research

Short-Acting Sedative-Analgesic Drugs Protect Against Development of Ventilator-Associated Events in Children: Secondary Analysis of the EUVAE Study

Yolanda Peña-López, Sergio Ramírez-Estrada, Marta Serrano-Megías, Leonel Lagunes, Jordi Rello; and for the EUVAE Study Group
Respiratory Care May 2021, 66 (5) 798-805; DOI: https://doi.org/10.4187/respcare.08597

References

  1. 1.↵
    1. Klompas M
    . Complications of mechanical ventilation–the CDC's new surveillance paradigm. N Engl J Med 2013;368(16):1472–1475.
    OpenUrlPubMed
  2. 2.↵
    1. Jansson M,
    2. Ala-Kokko T,
    3. Ahvenjärvi L,
    4. Karhu J,
    5. Ohtonen P,
    6. Syrjälä H
    . What is the applicability of a novel surveillance concept of ventilator-associated events? Infect Control Hosp Epidemiol 2017;38(8):983–988.
    OpenUrl
  3. 3.↵
    1. Klompas M,
    2. Berra L
    . Should ventilator-associated events become a quality indicator for ICUs? Respir Care 2016;61(6):723–736.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Klompas M,
    2. Anderson D,
    3. Trick W,
    4. Babcock H,
    5. Kerlin MP,
    6. Li L,
    7. et al
    ; CDC Prevention Epicenters. The preventability of ventilator-associated events. The CDC Prevention Epicenters Wake Up and Breathe Collaborative. Am J Respir Crit Care Med 2015;191(3):292–301.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Rello J,
    2. Ramírez-Estrada S,
    3. Romero A,
    4. Arvaniti K,
    5. Koulenti D,
    6. Nseir S,
    7. et al
    ; EUVAE Study Group. Factors associated with ventilator-associated events: an international multicenter prospective cohort study. Eur J Clin Microbiol Infect Dis 2019;38(9):1693–1699.
    OpenUrl
  6. 6.↵
    1. Guess R,
    2. Vaewpanich J,
    3. Coss-Bu JA,
    4. Phongjitsiri S,
    5. Kennedy C,
    6. Starke J,
    7. Thammasitboon S
    . Risk factors for ventilator-associated events in a PICU. Pediatr Crit Care Med 2018;19(1):e7–e13.
    OpenUrl
  7. 7.↵
    1. Iosifidis E,
    2. Chochliourou E,
    3. Violaki A,
    4. Chorafa E,
    5. Psachna S,
    6. Roumpou A,
    7. et al
    . Evaluation of the new centers for disease control and prevention ventilator-associated event module and criteria in critically ill children in Greece. Infect Control Hosp Epidemiol 2016;37(10):1162–1166.
    OpenUrl
  8. 8.↵
    1. Ramírez-Estrada S,
    2. Lagunes L,
    3. Peña-López Y,
    4. Vahedian-Azimi A,
    5. Nseir S,
    6. Arvaniti K,
    7. et al
    ; the EU-VAE Study Investigators Group. Assessing predictive accuracy for outcomes of ventilator-associated events in an international cohort: the EUVAE study. Intensive Care Med 2018;44(8):1212–1220.
    OpenUrl
  9. 9.↵
    1. Peña-López Y,
    2. Pujol M,
    3. Campins M,
    4. Lagunes L,
    5. Balcells J,
    6. Rello J
    . Assessing prediction accuracy for outcomes of ventilator-associated events and infections in critically ill children: a prospective cohort study. Clin Microbiol Infect 2018;24(7):732–737.
    OpenUrl
  10. 10.↵
    1. Fan Y,
    2. Gao F,
    3. Wu Y,
    4. Zhang J,
    5. Zhu M,
    6. Xiong L
    . Does ventilator-associated event surveillance detect ventilator-associated pneumonia in intensive care units? A systematic review and meta-analysis. Crit Care 2016;20(1):338.
    OpenUrl
  11. 11.↵
    1. Cocoros NM,
    2. Priebe GP,
    3. Logan LK,
    4. Coffin S,
    5. Larsen G,
    6. Toltzis P,
    7. et al
    . A pediatric approach to ventilator-associated events surveillance. Infect Control Hosp Epidemiol 2017;38(3):327–333.
    OpenUrl
  12. 12.↵
    1. Ramirez-Estrada S,
    2. Peña-López Y,
    3. Rello J
    . The effects of sedatives, neuromuscular blocking agents and opioids on ventilator-associated events. Eur J Anaesthesiol 2020;37(2):67–69.
    OpenUrl
  13. 13.↵
    1. Pollack MM,
    2. Patel KM,
    3. Ruttimann UE
    . PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 1996;24(5):743–752.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Peña-López Y,
    2. Ramirez-Estrada S,
    3. Eshwara VK,
    4. Rello J
    . Limiting ventilator-associated complications in ICU intubated subjects: strategies to prevent ventilator-associated events and improve outcomes. Expert Rev Respir Med 2018;12(12):1037–1050.
    OpenUrl
  15. 15.↵
    1. Liu J,
    2. Zhang S,
    3. Chen J,
    4. Mao Y,
    5. Shao X,
    6. Li Y,
    7. et al
    . Risk factors for ventilator-associated events: a prospective cohort study. Am J Infect Control 2019;47(7):744–749.
    OpenUrl
  16. 16.↵
    1. Lewis SC,
    2. Li L,
    3. Murphy MV,
    4. Klompas M
    , CDC Prevention Epicenters. Risk factors for ventilator-associated events: a case-control multivariable analysis. Crit Care Med 2014;42(8):1839–1848.
    OpenUrlPubMed
  17. 17.↵
    1. O'Horo JC,
    2. Lan H,
    3. Thongprayoon C,
    4. Schenck L,
    5. Ahmed A,
    6. Dziadzko M,
    7. et al
    . “Bundle” practices and ventilator-associated events: not enough. Infect Control Hosp Epidemiol 2016;37(12):1453–1457.
    OpenUrl
  18. 18.↵
    1. Harris BD,
    2. Thomas GA,
    3. Greene MH,
    4. Spires SS,
    5. Talbot TR
    . Ventilator bundle compliance and risk of ventilator-associated events. Infect Control Hosp Epidemiol 2018;39(6):637–643.
    OpenUrl
  19. 19.↵
    1. Deschepper M,
    2. Vogelaers D,
    3. Blot S
    . Chlorhexidine-related ventilator-associated events: toward recognition? Infect Control Hosp Epidemiol 2018;39(9):1144–1145.
    OpenUrl
  20. 20.↵
    1. Zheng Z,
    2. Jiang L,
    3. Zhang S,
    4. Guervilly C,
    5. Zhang M,
    6. Feng X,
    7. Ding J
    . Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials. Respir Res 2020;21(1):23.
    OpenUrl
  21. 21.↵
    1. Devlin JW,
    2. Skrobik Y,
    3. Gélinas C,
    4. Needham DM,
    5. Slooter AJC,
    6. Pandharipande PP,
    7. et al
    . Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med 2018;46(9):e825–e873.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Wang H,
    2. Wang C,
    3. Wang Y,
    4. Tong H,
    5. Feng Y,
    6. Li M,
    7. et al
    . Sedative drugs used for mechanically ventilated patients in intensive care units: a systematic review and network meta-analysis. Curr Med Res Opin 2019;35(3):435–446.
    OpenUrl
  23. 23.↵
    1. Spina SP,
    2. Ensom MHH
    . Clinical pharmacokinetic monitoring of midazolam in critically ill patients. Pharmacotherapy 2007;27(3):389–398.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Wyncoll D,
    2. McKenzie C
    . Sedation versus no sedation in the intensive-care unit. Lancet 2010;375(9721):1159; author reply 1160.
    OpenUrlPubMed
  25. 25.↵
    1. Krewulak KD,
    2. Stelfox HT,
    3. Leigh JP,
    4. Ely EW,
    5. Fiest KM
    . Incidence and prevalence of delirium subtypes in an adult ICU: a systematic review and meta-analysis. Crit Care Med 2018;46(12):2029–2035.
    OpenUrlPubMed
  26. 26.↵
    1. Traube C,
    2. Silver G,
    3. Gerber LM,
    4. Kaur S,
    5. Mauer EA,
    6. Kerson A,
    7. et al
    . Delirium and mortality in critically ill children: epidemiology and outcomes of pediatric delirium. Crit Care Med 2017;45(5):891–898.
    OpenUrl
  27. 27.↵
    1. Wesolowski AM,
    2. Zaccagnino MP,
    3. Malapero RJ,
    4. Kaye AD,
    5. Urman RD
    . Remimazolam: pharmacologic considerations and clinical role in anesthesiology. Pharmacotherapy 2016;36(9):1021–1027.
    OpenUrl
  28. 28.↵
    1. Hemphill S,
    2. McMenamin L,
    3. Bellamy MC,
    4. Hopkins PM
    . Propofol infusion syndrome: a structured literature review and analysis of published case reports. Br J Anaesth 2019;122(4):448–459.
    OpenUrlPubMed
  29. 29.↵
    1. Sheridan RL,
    2. Keaney T,
    3. Stoddard F,
    4. Enfanto R,
    5. Kadillack P,
    6. Breault B
    . Short-term propofol infusion as an adjunct to extubation in burned children. J Burn Care Rehabil 2003;24(6):356–360.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Romagnoli S,
    2. Amigoni A,
    3. Blangetti I,
    4. Casella G,
    5. Chelazzi C,
    6. Forfori F,
    7. et al
    . Light sedation with dexmedetomidine: a practical approach for the intensivist in different ICU patients. Minerva Anestesiol 2018;84(6):731–746.
    OpenUrlPubMed
  31. 31.
    1. Kim HY,
    2. Lee JE,
    3. Kim HY,
    4. Kim J
    . Volatile sedation in the intensive care unit: a systematic review and meta-analysis. Medicine (Baltimore) 2017;96(49):e8976.
    OpenUrl
  32. 32.
    1. Pavcnik M,
    2. Groselj GM
    . Sevoflurane sedation for weaning from mechanical ventilation in pediatric intensive care unit. Minerva Anestesiol 2019;85(9):951–961.
    OpenUrl
  33. 33.↵
    1. Mencía S,
    2. Palacios A,
    3. García M,
    4. Llorente AM,
    5. Ordóñez O,
    6. Toledo B,
    7. López-Herce J
    . An exploratory study of sevoflurane as an alternative for difficult sedation in critically ill children. Pediatr Crit Care Med 2018;19(7):e335–e341.
    OpenUrl
  34. 34.↵
    1. Whelan KT,
    2. Heckmann MK,
    3. Lincoln PA,
    4. Hamilton SM
    . Pediatric withdrawal identification and management. J Pediatr Intensive Care 2015;4(2):73–78.
    OpenUrl
  35. 35.↵
    1. Haenecour AS,
    2. Seto W,
    3. Urbain CM,
    4. Stephens D,
    5. Laussen PC,
    6. Balit CR
    . Prolonged dexmedetomidine infusion and drug withdrawal in critically ill children. J Pediatr Pharmacol Ther 2017;22(6):453–460.
    OpenUrl
  36. 36.↵
    1. Nakahashi S,
    2. Imai H,
    3. Imanaka H,
    4. Ohshimo S,
    5. Satou T,
    6. Shima M,
    7. et al
    . Ventilator-associated events: prevalence and mortality in Japan. J Thorac Dis 2018;10(12):6942–6949.
    OpenUrl
  37. 37.↵
    1. Younan D,
    2. Griffin R,
    3. Zaky A,
    4. Pittet J-F,
    5. Camins B
    . Burn patients with infection-related ventilator associated complications have worse outcomes compared to those without ventilator associated events. Am J Surg 2018;215(4):678–681.
    OpenUrl
  38. 38.↵
    1. Kallet RH
    . Ventilator bundles in transition: from prevention of ventilator-associated pneumonia to prevention of ventilator-associated events. Respir Care 2019;64(8):994–1006.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords